Linden Advisors’s Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CSTA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-252,258
Closed -$168K 792
2021
Q4
$168K Hold
252,258
﹤0.01% 670
2021
Q3
$170K Hold
252,258
﹤0.01% 599
2021
Q2
$226K Buy
+252,258
New +$195K ﹤0.01% 674

Other funds holding CSTA.WS

Linden Advisors's CSTA.WS Position: Q1 2022 in Review

Linden Advisors sold out of Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CSTA.WS) in Q1 2022, closing a stake of 252,258 shares — an estimated $168K sold.

Linden Advisors first reported a position in CSTA.WS in Q2 2021 and held it in 3 quarters. The position peaked at $226K in Q2 2021. 50 funds tracked by Wall St. Rank hold CSTA.WS as of Q1 2022.

  • Linden Advisors reported no remaining Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Linden Advisors sold 252,258 Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $168K.
  • Linden Advisors first reported a position in Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 3 quarters.
  • Linden Advisors's Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $226K in Q2 2021.
  • 50 funds tracked by Wall St. Rank held Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Linden Advisors's 13F filing for Q1 2022, filed 16 May 2022.